Upon analyzing the accumulated evidence that microbes inhabit or visit the brain and likely trigger Alzheimer’s disease, Leslie Norins, MD, PhD, concluded, “The suspects have been reliably placed at the crime scene.” Dr. Norins is CEO […]
The successful introduction of the 2018 Pharmabiotics Young Investigator Awards set the stage for its development as one of the most important and prestigious awards for young microbiome researchers. Co-initiated by the Pharmabiotic Research Institute […]
Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients, today announced that it has successfully completed an End-of-Phase 2 […]
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it […]
Trace Genomics®, a San Francisco Bay area startup developing revolutionary, AI-enabled diagnostic tools for farmers to increase yields and reduce costs, has closed a $13 million Series A round. Trace Genomics has launched the first […]
Newly published research shows that a saliva-based biomarker panel and associated algorithm could improve the ability to accurately identify children with autism spectrum disorder (ASD) in its earliest stages, announced Quadrant Biosciences Inc. In a […]
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, announces the randomisation of the first patient in a Phase II clinical trial of Blautix in patients with Irritable Bowel Syndrome […]
Pivot Bio and Monsanto Company, a member of the Bayer Group, announced today a collaboration entered into earlier this year to develop Bradyrhizobium strains with enhanced nitrogen production for U.S. soybean growers. Widely found in […]
The Danish Innovation Fund has awarded a grant to Chr. Hansen, University of Copenhagen and the Danish Technological Institute (DTI) who will join forces to develop natural solutions for sustainable agricultural production As global food […]
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, announced preclinical data for VE800, the Company’s orally-administered, live biotherapeutic product candidate in […]
Elanco Animal Health Incorporated (NYSE:ELAN), announced today a new global R&D collaboration with Novozymes A/S (OMX: NZYM B), the world leader in biological solutions, to develop nutritional health products for beef cattle and dairy cows […]